Back
Share

Molecular Therapy Oncolytics

Molecular Therapy Oncolytics is not currently indexed in Scopus, DOAJ. Published by Cell Press.

ISSN 2372-7705Verify ISSN ↗

Publisher: Cell Press

Scopus · InactiveOpen Access
1
Indexed in
major index

Cost to publish: Checking DOAJ for article charges…

Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.

Is Molecular Therapy Oncolytics indexed in Scopus? No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2014–2023).

What is the impact factor of Molecular Therapy Oncolytics? Molecular Therapy Oncolytics has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.

Is Molecular Therapy Oncolytics in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).

Is Molecular Therapy Oncolytics open access? Yes — it is an open-access journal, listed in DOAJ.

Impact & reach — open metrics via OpenAlex

69
h-index
0
2-yr mean citations
673
i10-index
820
works indexed
27,661
total citations
Papers published per year
01002002014: 10 papers1020142015: 18 papers1820152016: 44 papers4420162017: 32 papers3220172018: 41 papers4120182019: 83 papers8320192020: 170 papers17020202021: 189 papers18920212022: 140 papers14020222023: 93 papers932023

Molecular Therapy Oncolytics published 93 papers in 2023; its busiest recent year was 2021 with 189. 2026* is the year so far.

Main topics
Virus-based gene therapy researchCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer-related molecular mechanisms research

h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.

Integrity signals — indicators, not proof of misconduct

  • Scopus statusInactive — coverage ended 2023
  • Retracted papers 13 · 15.9 per 1,000 papers

Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.

Official sources & links

Related journals

← Back to Journal Finder

Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.